Amneal Pharmaceuticals, Inc. on Tuesday announced it has acquired Puniska Healthcare Pvt. Ltd. for a total value of $93 million, or approximately…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Healthcare
-
-
Gsk
GlaxoSmithKline’s Novel Anemia (Daprodustat) has Notched up A First-In-Class Success While AstraZeneca-FibroGen’s Akebia Failed.
by adminby adminSYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company is hoping will bolster its pharma portfolio…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
-
Active Pharmaceutical Ingredients (API)Covaxin
WHO grants Most-awaited Emergency Use Listing to Bharat Biotech’s Covaxin.
by adminby adminSUMMARY: WHO grant of EUL will ease international travel for those vaccinated with the Bharat Biotech`s Covaxin and the WHO clearance is a…
-
Bharat Biotech
Australia has added Bharat Biotech’s Covaxin to the approved list of COVID vaccines.
by adminby adminKEYPOINTS: Australia’s medicines and medical devices regulator on Monday formally recognised India’s Covaxin, a vaccine against the coronavirus as the country’s border…
-
Iptacopan
Novartis Pharmaceuticals UK awarded an Innovation Passport for Investigational Oral Therapy Iptacopan (LNP023)
by adminby adminSUMMARY: Iptacopan has been awarded the Innovation Passport for the treatment of C3 glomerulopathy (C3G) and is currently being investigated in a…
-
CabotegravirRilpivirine
European Commission Grants Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV
by adminby adminSUMMARY: ViiV Healthcare announces the European Commission Decision for Vocabria (Cabotegravir) and Rekambys (Rilpivirine) injections to be initiated with or without an…
-
Active Pharmaceutical Ingredients (API)Bharat BiotechCompaniesCovaxin
Covaxin approval: WHO’s technical advisory group to decide on 26 October.
by adminby adminWHO advisory group to meet on Oct 26 to decide on Bharat Biotech’s Covaxin. Covaxin manufacturer, Bharat Biotech, has been submitting data…
Older Posts